Blog

MilliporeSigma Receives Patent for CRISPR Technology in China – Canada NewsWire (press release)


MarketWatch

MilliporeSigma Receives Patent for CRISPR Technology in China
Canada NewsWire (press release)
Foundational CRISPR patents now granted in seven markets, including Canada and Europe. BURLINGTON, Mass., April 23, 2018 /CNW/ — MilliporeSigma, a leader in genome editing, today announced that the Chinese Patent Office has issued a notice granting
Merck receives patent for CRISPR tech in ChinaMarketWatch


Merck Receives Patent for CRISPR Technology in ChinaPR Newswire UK (press release)

all 2 news articles »

2018-04-23 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.